Prostate Small Cell Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-23
Clinical Trial Update: Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer [Phase 2]
This Phase 2 trial evaluates cabazitaxel, carboplatin, and cetrelimab with or without niraparib for aggressive variant metastatic prostate c…